Dianthus Therapeutics, Inc. (DNTH) Earnings
Dianthus Therapeutics, Inc. is expected to report next earnings on November 5, 2026 (in NaN days), with a consensus EPS estimate of $-1.02. DNTH has beaten EPS estimates in 4 of its last 12 reported quarters (average surprise -8.5% over the last four).
Next earnings
Nov 5, 2026in NaN days
EPS est $-1.02 · Revenue est $400833
Track record
Beat EPS in 4 of 12 quarters
Avg surprise -8.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 4, 2026 | $-0.85 | $-0.90 | -6.3% | $761000 | +156.1% |
| May 5, 2026 | $-1.17 | $-0.85 | +27.4% | $463000 | +14.7% |
| Mar 9, 2026 | $-1.01 | $-1.43 | -42.2% | $284000 | +17.2% |
| Nov 5, 2025 | $-0.86 | $-0.97 | -12.8% | $396000 | -0.5% |
| Aug 7, 2025 | $-0.86 | $-0.88 | -2.3% | $193000 | -77.7% |
| Mar 11, 2025 | $-0.85 | $-0.81 | +4.7% | $1M | +38.8% |
| Nov 7, 2024 | $-0.59 | $-0.74 | -25.4% | $2M | +157.3% |
| Aug 8, 2024 | $-0.50 | $-0.51 | -2.0% | $2M | +482.2% |
| May 9, 2024 | $-0.43 | $-0.54 | -25.6% | $874000 | +90.0% |
| Mar 21, 2024 | $-1.11 | $-0.71 | +36.0% | $457000 | +47.4% |
| Nov 9, 2023 | $-0.51 | $-3.78 | -641.2% | $924000 | +125.4% |
| Aug 3, 2023 | $-0.19 | $-0.05 | +73.7% | $969000 | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.